Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Female Sexual Dysfunction
Transdermal Testosterone Gel Looks Like Promising Therapy
October 4th, 2001
Cellegy Pharmaceuticals, Inc. (CLGY) announced that it has successfully completed a second Phase I/II clinical trial using Tostrelle, its transdermal testosterone gel product for the treatment of female sexual dysfunction. Testosterone deficiency in women frequently leads to diminished libido, decreased muscle/bone mass, and reduced energy levels. A meeting has been requested with the U.S. Food and Drug Administration (FDA) to review results of trials conducted to date and Cellegy's proposed protocol for an advanced efficacy trial. The 36-patient trial, conducted in the United Kingdom, was designed to determine the dose of Tostrelle required to...
Source: Women's Health Weekly (2001-10-04)
|
